Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Caco-2 cell model for CRISPR/CAS9-mediated drug transporter targeted knockout and method thereof

A cell model and transporter technology, applied in the field of genetic engineering, can solve problems such as affecting the analysis of results, and achieve the effect of eliminating mutual interference and sensitive cell models

Pending Publication Date: 2018-03-06
SOUTH CHINA UNIV OF TECH
View PDF5 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the cross-reactivity of the three substrates and inhibitors seriously affects the result analysis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Caco-2 cell model for CRISPR/CAS9-mediated drug transporter targeted knockout and method thereof
  • Caco-2 cell model for CRISPR/CAS9-mediated drug transporter targeted knockout and method thereof
  • Caco-2 cell model for CRISPR/CAS9-mediated drug transporter targeted knockout and method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] In the embodiment of the present invention, the CRISPR / CAS9-mediated drug transporter-targeted knockout method of the caco-2 cell model, which is used for non-diagnostic or therapeutic purposes, specifically includes the following steps:

[0028] 1. Design target-specific sgRNAs for the main members of the ABC family, P-gp, BCRP and MRP2, construct their expression vectors, and test the effectiveness of gene knockout.

[0029] Design specific sgRNAs for the gene expression functional regions of P-gp (NG_011513.1-ABCB1-Pgp), BCRP (NG_032067.2-ABCG2-BCRP) and MRP2 (NG_011798.1-ABCC2-MRP2), and perform off-target analyze. Two sgRNAs with good specificity and low off-target were screened for each gene, and the design results of sgRNAs for P-gp, BCRP and MRP2 are shown in Table 1.

[0030] Table 1

[0031]

[0032] U6 promoter was used to express sgRNA, and the designed sgRNA sequence was synthesized into Oligo to construct sgRNA expression vector U6-sgRNA. All were su...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a caco-2 cell model for CRISPR / CAS9-mediated drug transporter targeted knockout and a method thereof. The method is used for non-diagnostic or therapeutic purposes and comprises the following steps: designing sgRNA with target specificity for P-gp, BCRP and MRP2 transporters and constructing a sgRNA expression vector, wherein a sequence of the designed sgRNA is shown as SEQID NO. 1-6 in a sequence table; respectively designing P-gp, BCRP and MRP gene single knockout and pairwise combination double knockout by utilizing CRISPR / CAS9, co-transfecting a caco-2 cell with anhCas9 plasmid and performing monoclonal expansion culture to obtain the caco-2 cell model for transporter gene targeting. The caco-2 cell model obtained by the method disclosed by the invention has the beneficial effects that the mutual interference among different transporters is effectively eliminated, and a more specific and more sensitive cell model is provided for drug transport research.

Description

technical field [0001] The invention relates to the field of genetic engineering, in particular to a caco-2 cell model and a method for CRISPR / CAS9-mediated targeted knockout of drug transporters. Background technique [0002] Drug transport research is an important part of the new drug development process. The transporter performs secondary active transport through the transporter, that is, it relies on the potential energy of the high concentration of sodium ions in the extracellular space (the potential energy is provided by the primary active transport), which is equivalent to indirectly consuming the energy of ATP. For example, during the active absorption of glucose by the epithelial cells of the small intestinal mucosa, the transport energy does not come directly from the decomposition of ATP, but depends on the concentration gradient of sodium ions between the epithelial cells (low) and the intestinal fluid (high). When the concentration gradient enters the epitheli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/85
CPCC07K14/47C12N5/0693C12N15/85C12N2800/80C12N2810/10
Inventor 黄黎珍钟国瑞谢水林庞土慧姜二岗邹淑香李浩健戴仁科
Owner SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com